home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

New Anti-Inflammatory Arthritis Drugs

  November, 26 2008 18:38
your information resource in human molecular genetics
Researchers report a new class of anti-inflammatory drugs that stop the progression of collagen-induced arthritis in mice. The drugs, described online in Immunology and Cell Biology, could be used for the treatment of similar diseases in humans, such as rheumatoid arthritis and systemic lupus erythematosus.

Rheumatoid arthritis is an autoimmune disorder with unknown causes. Treatments for the disease are aimed at relieving pain and swelling, slowing disease progression and preventing cartilage and bone destruction. Geoffrey Pietersz, Mark Hogath and colleagues have designed a small chemical molecule based on the structure of FcgammaRIIa - a molecule known to have a pivotal role in causing inflammation associated with the disease. The team find that the new drug suppresses disease for longer than either of the current commonly used drugs - methotrexate and anti-CD3.

These findings in mice point to the potential of FcgammaRIIa receptor agonists as valid targets for new and potentially more effective therapies to prevent the progression of inflammatory diseases in humans.

Author contact:

Geoffrey Pietersz (Burnet Institute Austin Campus, Austin Hospital, Heidelberg, Victoria, Australia)
E-mail: gpietersz@burnet.edu.au

Abstract available online.

(C) Immunology and Cell Biology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.